Anti-thrombotic therapy for elderly patients with acute coronary syndromes

被引：3
|
作者：
Chen, YT
Tuohy, ER
Krumholz, HM
机构：
[1] Yale Univ, Sch Med, Sect Cardiovasc Med,Dept Med, New Haven Hosp Ctr Outcomes Res & Evaluat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT 06520 USA
[3] QUALIDIGM, Middletown, CT USA
来源：
CORONARY ARTERY DISEASE | 2000年 / 11卷 / 04期
关键词：
D O I：
10.1097/00019501-200006000-00005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：323 / 330
页数：8
相关论文
共 50 条
  • [1] Novel anti-thrombotic therapy in acute coronary syndromes
    Aziz, Amir
    Aziz, Shabeena
    Wheatcroft, Stephen B.
    COR ET VASA, 2013, 55 (02) : E117 - E125
  • [2] Anti-thrombotic therapy of acute coronary syndromes without ST elevation
    Montalescot, G
    Payot, L
    Collet, JP
    Choussat, R
    Beygui, F
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (02): : 217 - 225
  • [3] Anti-thrombotic therapy of acute coronary syndromes without ST elevation - Discussion
    Dreux, MC
    Grosgogeat, MY
    Vacheron, MA
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (02): : 225 - 226
  • [4] Current and emerging anti-thrombotic therapies for acute coronary syndromes
    Topol, EJ
    JOURNAL OF INVASIVE CARDIOLOGY, 1998, 10 : 2D - 7D
  • [5] Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes?
    Damås, JK
    Puccetti, L
    Aukrust, P
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) : 1 - 3
  • [6] Anti-thrombotic therapy in cancer patients
    Lee, AYY
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) : 2213 - 2220
  • [7] Risks and Benefits of Triple Oral Anti-Thrombotic Therapies After Acute Coronary Syndromes and Percutaneous Coronary Intervention
    Alfredsson, Joakim
    Roe, Matthew T.
    DRUG SAFETY, 2015, 38 (05) : 481 - 491
  • [8] Risks and Benefits of Triple Oral Anti-Thrombotic Therapies After Acute Coronary Syndromes and Percutaneous Coronary Intervention
    Joakim Alfredsson
    Matthew T. Roe
    Drug Safety, 2015, 38 : 481 - 491
  • [9] Management of epistaxis in patients with anti-thrombotic therapy
    Martin-Bailon, Maria
    Lopez-Mesa, Paula
    Dios-Loureiro, Cristina
    REVISTA ORL, 2021, 12 (02) : 11 - 18
  • [10] Anti-thrombotic therapy in diabetic patients: revisited
    Stratmann, Bernd
    Tschoepe, Diethelm
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (03) : 253 - 255
12345